Edward M Johnson

Title: Edward M Johnson: Innovator in Synthetic Peptides

Introduction

Edward M Johnson is a notable inventor based in Norfolk, VA (US). He has made significant contributions to the field of synthetic peptides, particularly in their application for cancer treatment and genetic modulation. His work is recognized for its potential impact on various debilitating diseases.

Latest Patents

Johnson holds a patent for a "Family of synthetic polynucleotide-binding peptides and uses thereof." This invention provides novel synthetic peptides, including the TZIP peptide, which serve as oncogenic and genetic modulators. These peptides are particularly useful for inhibiting the proliferation of cancer cells characterized by amplified c-MYC genes. The patent outlines methods for therapeutic uses of these peptides in treating various cancers, including small cell lung carcinoma, prostate cancer, lymphoma, brain tumors, colon cancer, bladder cancer, acute myeloid leukemia, malignant melanoma, mesothelioma, and cancers of the head and neck. Additionally, the peptides are beneficial in the treatment and prevention of HIV transmission and in addressing expanded nucleotide repeat diseases.

Career Highlights

Edward M Johnson is affiliated with Eastern Virginia Medical School, where he continues to advance his research in synthetic peptides. His work has garnered attention for its innovative approach to tackling complex medical challenges.

Collaborations

Johnson collaborates with Dianne C Daniel, contributing to the advancement of research in their respective fields. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Edward M Johnson's contributions to the field of synthetic peptides highlight his role as a significant inventor in medical research. His innovative approaches have the potential to change the landscape of cancer treatment and genetic modulation.